AbbVie Pays $200M to Settle Opioid Marketing Case Right Before Trial Ends

 

 

 
AbbVie Inc. agreed to pay $200 million to settle claims by New York that its Allergan unit helped fuel an epidemic of opioid addiction in the state, shortly before jurors heard closing arguments from remaining defendant Teva Pharmaceutical Industries Ltd. …

from News – Insurance Journal https://ift.tt/3oC5QKm
via IFTTT